Botox approved for the prevention of chronic migraine

Botox has been approved as a preventive treatment for chronic migraine by UK drug regulators.

It comes after a trial of more than 1,300 patients showed success in reducing the frequency of headaches.

But only patients who suffer headaches for at least 15 days a month, half of which come with migraine symptoms, are eligible, the Medicines and Healthcare Products Regulatory Agency said ..read more here..